Subscribe
Pip-Tazo vs Meropenem for GNR Bacteremia, Vessel Recanalization in Stroke, Ioannidis on Reforming Nutritional Research, and more

JAMA Editor’s Summary

Pip-Tazo vs Meropenem for GNR Bacteremia, Vessel Recanalization in Stroke, Ioannidis on Reforming Nutritional Research, and more

Editor's Summary by Phil Fontanarosa, MD, Executive Editor of JAMA, the Journal of the American Medical Association, for the September 11, 2018 issue
September 11, 2018
ADVERTISEMENT
WP Engine Wordpress Hosting

Pip-Tazo vs Meropenem for GNR Bacteremia, Vessel Recanalization in Stroke, Ioannidis on Reforming Nutritional Research, and more

Editor’s Summary by Phil Fontanarosa, MD, Executive Editor of JAMA, the Journal of the American Medical Association, for the September 11, 2018 issue

ADVERTISEMENT
WP Engine Wordpress Hosting

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.